1. Introduction {#sec1-animals-10-01392}
===============

The negative impacts of nitrogen (N) emissions from animal husbandry can be diminished by reducing dietary crude protein (CP) in feeds. Very low CP diets are often accompanied by decreased growth in broiler chickens when the nonessential amino acids (AA) glycine (Gly) and serine (Ser)---considered together as glycine equivalent (Gly~equi~)---are not adequately supplied because these AA can induce a growth limiting effect \[[@B1-animals-10-01392],[@B2-animals-10-01392],[@B3-animals-10-01392]\]. The Gly~equi~ requirement is not constant, with dietary Gly~equi~ concentrations varying from below 10 to above 16 g/kg among studies to achieve 95% of the maximum gain:feed ratio (G:F) \[[@B4-animals-10-01392]\]. These variations were explained by different amounts of Gly~equi~ being dissipated for metabolic processes and by varying dietary concentrations of endogenous precursors of Gly and Ser.

One metabolic process for which Gly~equi~ is required is the endogenous formation of cysteine (Cys) from methionine (Met). Homocysteine (Hcy) and cystathionine (Cysta) are intermediates in this metabolic conversion, and Ser is required to form Cysta from Hcy \[[@B5-animals-10-01392]\]. This was suggested as one explanation for the interactive effects between dietary Gly~equi~ and Cys on growth found in a previous meta-analysis \[[@B6-animals-10-01392]\]. The extent of these interactive effects cannot be explained only by the formation of Cys from Met. Further influences must have been responsible for the extent of interactive effects between dietary Gly~equi~ and Cys on growth found in the meta-analysis by Siegert et al. \[[@B6-animals-10-01392]\].

Choline (Cho) is an endogenous precursor of Gly in the metabolic pathway involving the conversion of Cho → betaine → dimethylglycine → sarcosine → Gly \[[@B7-animals-10-01392]\]. The conversion of Cho to Gly is connected to Cys formation from Met and can only occur when one methyl group of betaine is transferred to Hcy by betaine-Hcy-methyltransferase (BHMT; EC 2.1.1.5) to form Met \[[@B8-animals-10-01392]\]. Concurrently, Met can be synthesized by transferring the methyl groups of dimethylglycine and sarcosine via the folate pool to Hcy by Met-synthase (MS; EC 2.1.1.13) \[[@B9-animals-10-01392]\]. Interactive effects between Gly~equi~ and Cho on growth have been described previously; however, the extent of these interactive effects cannot alone be explained by the endogenous conversion of Cho to Gly \[[@B10-animals-10-01392]\]. Therefore, varying dietary Cys concentrations that affect the conversion of Hcy to Met could influence the extent of interactive effects between Gly~equi~ and Cho on growth. Further, Cho as a methyl group donor and precursor of Gly might provide a further explanation regarding the interactive effects of Gly~equi~ and Cys on growth as observed in the meta-analysis by Siegert et al. \[[@B6-animals-10-01392]\].

The formation of uric acid (UA) is a Gly~equi~-dissipating process because one molecule of Gly is required to form the purine ring of UA \[[@B11-animals-10-01392]\]. An increase in nitrogen-utilization efficiency (NUE) leads to less urinary UA-N excretion, resulting in decreased Gly~equi~ requirement with increasing NUE \[[@B4-animals-10-01392]\]. Therefore, varying NUE influences the response to dietary Gly~equi~ and likely affects the interactive effects among Gly~equi~, Cys, and Cho on growth.

We hypothesized that investigating different dietary concentrations of Gly~equi~, Cys, and Cho together could explain the interactive effects between Gly~equi~ and Cys and between Gly~equi~ and Cho that have previously been found in other studies. Therefore, we investigated the interactive effects among dietary Gly~equi~, Cys, and Cho in a growth study. Digestibility was analyzed to determine the prececal digestible AA intake. Total N excretion was measured to determine NUE, and plasma metabolites were analyzed as indicators of metabolism of Gly~equi~, Cys, and Cho. Neural networks optimized with genetic algorithms were used for data evaluation.

2. Materials and Methods {#sec2-animals-10-01392}
========================

2.1. Experimental Design {#sec2dot1-animals-10-01392}
------------------------

Two trials were run simultaneously. All dietary treatments were randomly distributed in a completely randomized block design.

A growth trial was conducted to investigate the interactive effects among dietary Gly~equi~, Cys, and Cho at five concentrations on growth, total N excretion, and plasma metabolites. A fractional central composite design \[[@B12-animals-10-01392]\] was used. This resulted in 15 dietary treatments that were tested in seven replicates each.

A digestibility trial was undertaken to determine the prececal AA digestibility of one diet in five replicates. This was done to obtain the prececal digestible AA concentrations of diets used in the growth trial.

2.2. Birds and Housing {#sec2dot2-animals-10-01392}
----------------------

The experiment was performed at the Agricultural Experiment Station of the University of Hohenheim, Germany. It was approved by the Regierungspräsidium Tübingen, Germany (Project no. HOH 48/17 TE), and was conducted according to the German Animal Welfare Legislation. Male Ross 308 broiler hatchlings were delivered by a commercial hatchery (Brüterei Süd ZN der BWE-Brüterei Weser-Ems GmbH & Co. KG, Regenstauf, Germany). Birds were held in five floor pens (3 m × 4 m) on dedusted wood shavings and received a commercial starter diet containing 215 g CP/kg and 12.5 MJ ME/kg (415002025 Club Mastkükenstarter, Deutsche Tiernahrung Cremer GmbH & Co. KG, Mannheim, Germany) up to day 7. Then, 1125 birds were distributed to metabolism units and placed on a mesh-wired floor. The birds were allocated to the metabolism units so that an equal mean bird weight was achieved in every unit of both the trials. Feed and water were provided for ad libitum consumption throughout the experiment. Lighting was continuous during the first 3 days after placement, followed by 18-h light and 6-h dark cycle until the end of the experiment. Temperature was maintained at 34 °C for the first 3 days and was gradually decreased to 26 °C on the last day of the experiment.

In the growth trial, a total of 1050 broiler chickens were distributed to 105 (1 m × 1 m × 1 m) metabolism units. Each diet was tested in 7 metabolism units and each metabolism unit contained 10 birds. The experimental diets were fed from days 7 to 22.

In the digestibility trial, 15 out of 75 birds were assigned to one of five (2 m × 1 m × 1 m) metabolism units. The birds received the experimental diets from days 7 to 21.

2.3. Experimental Diets {#sec2dot3-animals-10-01392}
-----------------------

The diets were mainly based on corn and casein ([Table 1](#animals-10-01392-t001){ref-type="table"}) and were mixed at the certified feed mill of the University of Hohenheim. Concentrations of all nutrients listed herein are based on a standardized dry matter (DM) of 88%, unless otherwise stated. The concentrations of essential AA including Met + Cys were calculated at 105% of the recommendations of the Gesellschaft für Ernährungsphysiologie \[[@B13-animals-10-01392]\]. The concentrations of the nonessential AA alanine, aspartic acid/asparagine, and glutamic acid/glutamine were calculated at 8.6, 15.4, and 28.1 g/kg, respectively, because lower concentrations of these AA cause limited growth \[[@B14-animals-10-01392]\]. Concentrations of AA were adjusted by adding AA in free form. Other nutrients were formulated to meet or exceed the recommendations of the Gesellschaft für Ernährungsphysiologie \[[@B13-animals-10-01392]\].

In the growth trial, different concentrations of dietary Gly~equi~ (9, 12, 15, 18, and 21 g/kg), Cys (2.0, 2.75, 3.5, 4.25, and 5.0 g/kg), and Cho (0.5, 0.8, 1.1, 1.4, and 1.7 g/kg) ([Table 2](#animals-10-01392-t002){ref-type="table"}) were obtained by adding free Gly, free [l]{.smallcaps}-Cys·HCl·H~2~O, and choline chloride in variable proportions to a basal mixture. Free [dl]{.smallcaps}-Met inclusions were altered to ensure constant Met + Cys concentrations among treatments. Cornstarch was used to compensate for mass differences. Gly~equi~ concentrations used in this study were similar to those that were shown to influence growth in the literature \[[@B4-animals-10-01392]\]. Cho concentrations were calculated according to those reported by Siegert et al. \[[@B10-animals-10-01392]\], and Cys concentrations were calculated to include the range of Cys concentrations reported in the meta-analysis by Siegert et al. \[[@B6-animals-10-01392]\].

The diet fed in the digestibility trial was mixed using the same basal mixture utilized for the growth trial. The concentrations of dietary Gly~equi~, Cys, and Met were equal to the lowest concentrations of these nutrients in the growth trial. TiO~2~ was added as an indigestible marker.

One basal mixture that represented approximately 98% of the final diets of both trials was established, divided into 16 parts, and complemented with the ingredients required for the final diets. The diets were pelleted without using steam through a 3-mm die. The calculated AA concentrations were confirmed by analyses. The variation of the analyzed AA (apart from Gly~equi~, Cys, and Met) was low among the treatments ([Table 2](#animals-10-01392-t002){ref-type="table"} and [Table S1](#app1-animals-10-01392){ref-type="app"}). Dietary CP ranged between 172 and 185 g/kg. The analyzed Cho concentrations were within the 15% range of measurement accuracy, thus confirming the calculated values. Calculated dietary Cho concentrations were used for subsequent calculations.

2.4. Experimental Procedures {#sec2dot4-animals-10-01392}
----------------------------

In the growth trial, total bird weight and feed consumption in each metabolism unit were recorded on days 7, 18, and 21 of the experiment to determine the mortality-corrected average daily gain (ADG), average daily feed intake (ADFI), and G:F. Feed intake was measured on a DM basis by determining the DM content of each diet on the same days. Total excreta were collected at 12-h intervals from days 18 to 21 of the experiment. Excreta were carefully cleaned to remove feathers, skin scales, and spilled feed pellets before each collection and then immediately stored at −20 °C. Spilled feed was picked up throughout the experiment, weighed after being dried, and used for correction of feed DM intake. The excreta of birds collected in four metabolism units were not used for data analysis because of errors during excreta collection. The birds were examined at least twice daily. In the case of death, dead birds were considered in the calculation of ADG, ADFI, and G:F. Blood was sampled on day 22 from the brachial vein of one bird per metabolism unit and was placed into a 4 mL heparinized tube. The bird whose body weight was the closest to the mean body weight of birds in each unit was selected for blood sampling. The feeding regime according to Donsbough et al. \[[@B15-animals-10-01392]\] described in detail by Hofmann et al. \[[@B14-animals-10-01392]\] was used before blood sampling. The sample was immediately centrifuged at 1500× *g* for 10 min at 4 °C, and the resulting blood plasma was frozen at −20 °C.

In the digestibility trial, birds were fed the diet with medium concentrations of Gly~equi~, Cys, Met, and Cho (treatment H in the growth trial) from days 7 to 16 to ensure similar physiological development of the birds in the two trials. Subsequently, they received diet P (with the lowest concentrations of Gly~equi~, Cys, and Met). On day 21, the birds were stunned with a gas mixture of 35% CO~2~, 35% N~2~, and 30% O~2~ and euthanized with CO~2~ exposure. Digesta was collected from the distal two-thirds of the section between diverticulum vitellinum and 2 cm anterior to the ileo-ceco-colonic junction by flushing with cold, double-distilled water. Digesta of the 15 birds in each metabolism unit was pooled and immediately frozen at −20 °C.

2.5. Chemical Analyses {#sec2dot5-animals-10-01392}
----------------------

Diet H was ground using a centrifugal mill (ZM 200; Retsch GmbH, Haan, Germany) through a 0.5 mm sieve to analyze it for crude ash (method no. 8.1), crude fat (method no. 5.1.1), crude fiber (method no. 6.1.1), DM (method no. 3.1), and starch (method no. 7.2.1) according to the official methods for nutrient analyses in Germany \[[@B16-animals-10-01392]\]. A vibrating cup mill (Pulverisette 9; Fritsch GmbH, Idar−Oberstein, Germany) was used to pulverize all diets and freeze−dried digesta and excreta for AA, CP, Ti, and UA analyses. CP concentration was determined using the Dumas method. The official method 994.12 of the Association of Official Analytical Chemists \[[@B17-animals-10-01392]\] was used for AA analysis, with minor laboratory adaptions described by Siegert et al. \[[@B10-animals-10-01392]\]. CP and AA were analyzed by Evonik Nutrition & Care GmbH (Hanau, Germany). Ti was analyzed as described previously \[[@B18-animals-10-01392]\]. Cho was analyzed using the method outlined by Siegert et al. \[[@B10-animals-10-01392]\] by LUFA−ITL GmbH (Kiel, Germany). At least one diet per Cho concentration was analyzed to confirm the values calculated during diet formulation. Accurate quantification of Cho concentrations in digesta was not possible with a limit of quantification of 0.2 g/kg DM; therefore, the digestibility of Cho was not determined. The preparation of excreta samples and determination of DM, N, ammonia (NH~3~), and UA in the excreta were conducted according to the method described by Hofmann et al. \[[@B14-animals-10-01392]\]. One milliliter of each blood plasma sample was freeze-dried before being analyzed for free AA and biogenic amines by Evonik Nutrition & Care GmbH (Hanau, Germany). Freeze-dried blood plasma was resolubilized with lithium citrate buffer solution and peptides and proteins were precipitated using sulfosalicylic acid. AA were separated using the Biochrom 30 AA analyzer (Biochrom Ltd., Cambridge, UK). The separated AA were then mixed with ninhydrin and quantified photometrically. Blood plasma biogenic amines were determined using high-performance liquid chromatography with fluorescence detection after pre-column derivatization with dansyl chloride and liquid−liquid extraction with methyl tert-butyl ether. Measured homocystine (Hcys) was used to conclude on Hcy concentrations.

2.6. Calculations {#sec2dot6-animals-10-01392}
-----------------

The following equations were used to calculate N accretion and NUE:

The uric acid-nitrogen/(uric acid-nitrogen + ammonia-nitrogen) \[UA-N/(UA-N + NH~3~-N)\] ratio in the excreta was calculated because it has been reported to be suitable for interpreting the physiological processes of N metabolism in broiler chickens \[[@B14-animals-10-01392],[@B19-animals-10-01392]\]. Prececal AA digestibility was calculated using the following equation: where, AA~Diet~ and AA~Digesta~ are the concentrations of the individual AA and TiO~2Diet~ and TiO~2Digesta~ are the TiO~2~ concentrations in the diet and the digesta, respectively. Concentrations of prececal digestible Gly~equi~ (dGly~equi~), Cys (dCys), and Met (dMet) in the growth trial diets were determined using digestible AA concentrations determined in the digestibility trial and assuming complete digestibility of free AA. The daily intake of dGly~equi~, dCys, dMet, or Cho was measured for each metabolism unit by multiplying the concentrations of dGly~equi~, dCys, dMet, or Cho with the respective ADFI.

2.7. Data Modeling and Optimization {#sec2dot7-animals-10-01392}
-----------------------------------

Supervised, fully connected, feed forward neural networks optimized using genetic algorithms were used for data modeling and optimization using MatLab R2017b (The MathWorks Inc., Natick, MA, USA). Genetic algorithms were used to optimize the neural networks by modifying the number of neurons and their coefficients in the hidden layer to minimize mean squared error (MSE). The training of neural networks initiated with one neuron in the hidden layer. The parameters specifying the genetic algorithm \[[@B20-animals-10-01392]\] were as follows: initial population of 50, generation number of 1000, mutation rate of 0.1, and crossover rate of 0.85. The roulette wheel selection method was used for selecting the elite populations for crossover. An MSE of 0.001 was used as the performance function. Hyperbolic tangent and linear functions were the transfer functions for the hidden and output layers, respectively \[[@B21-animals-10-01392]\]. The dataset was randomly divided into 70% training and 30% testing set for each model. Independent models were developed for each response trait. The evaluation of model performance was based on the accuracy of model predictions in the training, testing, and entire data sets using the coefficient of determination (R^2^) and root MSE. The intake of dGly~equi~, dCys, and Cho were the independent input variables used for data evaluation because nutrient intake accurately describes the nutrient supply of the birds. The relevance of an input variable to the model performance was determined using the variable total effect (VTE) \[[@B22-animals-10-01392]\], which represents the contribution of an input variable to the variance of a model output. Higher VTE values indicate a higher influence of input variables on model performance. In addition to defining neural networks, genetic algorithms were utilized to analyze the developed neural network models to find combinations of dGly~equi~, dCys, and Cho intake for maximized and minimized responses. Regression analyses were performed to determine the dietary concentrations corresponding to the respective intake of digestible nutrients using GraphPad Prism 5.0 (GraphPad Software Inc., San Diego, CA, USA). Figures were prepared using the same software. According to the fractional composite design, not all level combinations can be shown without extrapolating, and the range where interactions can be interpreted decreased with the deviance from level 0. Therefore, levels −1, 0, and +1 were defined as low, medium, and high dCys and Cho intake levels, and ranges of dGly~equi~ intake are presented to be wider than high and low dCys and Cho intake. We decided that the relationships between the measured traits and varying nutrients were too low and were not further described when R^2^ ≤ 0.50.

3. Results {#sec3-animals-10-01392}
==========

The initial bird weights among metabolism units ranged between 180 and 191 (standard deviation \[SD\] 2.7) g/bird on day 7 and were not significantly different among treatments (*p* = 0.885). The survival rate during the experimental phase was ≥ 96% and was independent of treatment (27 out of 1050 birds died in 11 different treatments in the growth trial and 3 out of 75 birds died in the digestibility trial).

3.1. Neural Network Model Characteristics {#sec3dot1-animals-10-01392}
-----------------------------------------

The characteristics of models for traits with R^2^ \> 0.50 that were used for further interpretations are described in [Table 3](#animals-10-01392-t003){ref-type="table"} and [Table 4](#animals-10-01392-t004){ref-type="table"}, and the corresponding model equations are shown in [Table S2](#app1-animals-10-01392){ref-type="app"}. The descriptions of neural network models for traits with R^2^ ≤ 0.50 are shown in [Table S3](#app1-animals-10-01392){ref-type="app"}. Maximum output values were determined at extrapolated dGly~equi~, dCys, and Cho intake levels for all traits. Hence, these combinations are not presented.

3.2. Prececal Amino Acid Digestibility and Prececal Digestible Nutrient Intake {#sec3dot2-animals-10-01392}
------------------------------------------------------------------------------

Prececal AA digestibility in the digestibility trial was between 81% for Cys and 96% for arginine and was higher than 90% for most AA ([Table 5](#animals-10-01392-t005){ref-type="table"}). Prececal digestibility of Gly, Ser, Cys, and Met was 84%, 84%, 81%, and 95%, respectively. The regression equations used to calculate the dietary concentrations from the intake of digestible nutrients were linear ([Figure 1](#animals-10-01392-f001){ref-type="fig"}).

3.3. Global Sensitivity Analysis {#sec3dot3-animals-10-01392}
--------------------------------

Results of the global sensitivity analysis indicating the importance of independent variables ([Table 6](#animals-10-01392-t006){ref-type="table"}) were ranked via the intake of dGly~equi~ \> dCys \> Cho for G:F, NUE, UA excretion, UA-N/(UA-N + NH~3~-N) ratio, and plasma Gly concentration, the intake of dCys \> Cho \> dGly~equi~ for NH~3~ excretion and plasma Met, Hcys, and Cysta concentrations, and the intake of dGly~equi~ \> Cho \> dCys for total N excretion.

3.4. Average Daily Gain and Average Daily Feed Intake {#sec3dot4-animals-10-01392}
-----------------------------------------------------

Neural networks showed strong relationships among the nutrients and ADG and ADFI (R^2^ ≥ 0.93), and variation in these traits was low (57.0--68.7 g/bird for ADG and 72.7--82.9 g/bird for ADFI). However, the modeled curve shapes of these traits were undulated ([Figures S1 and S2](#app1-animals-10-01392){ref-type="app"}) and, therefore, biologically implausible. Similar high R^2^ and undulated curve shapes were obtained when neural networks with a high number of preset model parameter combinations were used instead of using combinations of model parameters that were obtained from genetic algorithms. Furthermore, data analysis by using full quadratic models including interaction effects did not adequately describe ADG and ADFI (data not shown). We concluded that the obtained models for ADG and ADFI from all evaluations were unsuitable, and these traits are not further described herein.

3.5. Gain:Feed Ratio {#sec3dot5-animals-10-01392}
--------------------

Values of G:F from days 7 to 21 increased with dGly~equi~ intake, particularly up to a dGly~equi~ intake of 900 mg/day ([Figure 2](#animals-10-01392-f002){ref-type="fig"}). Overall, G:F increased with higher dCys intake. The highest difference in G:F between high and low dCys intake was 0.011 g/g at a dGly~equi~ intake of 956 mg/day. The G:F was approximately 0.83 g/g with different dCys intakes and at a dGly~equi~ intake above 1170 mg/day. An effect of Cho intake on G:F was barely pronounced compared with that of dGly~equi~ and dCys intake. G:F slightly increased with low Cho and high dCys intake and the highest difference between low and high Cho intake was 0.004 g/g at 1034 mg of dGly~equi~ intake/day.

3.6. Nitrogen-Utilization Efficiency {#sec3dot6-animals-10-01392}
------------------------------------

Values of NUE varied between 76.7% and 80.2% for medium Cho intake ([Figure 3](#animals-10-01392-f003){ref-type="fig"}a). The NUE increased with low, medium, and high dCys intake up to a dGly~equi~ intake threshold of 1364, 1474 and 1392 mg/day, respectively, and decreased at higher intake levels of dGly~equi~. The NUE was the highest at medium dCys intake; it was higher at low dCys intake than at high dCys intake. Differences in NUE with different Cho intakes and with low dCys intake were small ([Figure 3](#animals-10-01392-f003){ref-type="fig"}b). At medium dCys intake ([Figure 3](#animals-10-01392-f003){ref-type="fig"}c), the influence of high and low Cho intake on NUE up to a dGly~equi~ intake of approximately 1650 mg/d was low. At high Gly~equi~ intake, NUE increased and decreased with low and high Cho intake, respectively. With high dCys intake ([Figure 3](#animals-10-01392-f003){ref-type="fig"}d), the response to dGly~equi~ was similar with different Cho intake levels, with higher NUE at the low Cho intake compared to medium and high Cho intake.

3.7. Nitrogen Excretion {#sec3dot7-animals-10-01392}
-----------------------

Total N and UA excretion increased with medium Cho intake when dGly~equi~ intake was higher than 1250 and 1410 mg/day, respectively ([Figure 4](#animals-10-01392-f004){ref-type="fig"}a and [Figure 5](#animals-10-01392-f005){ref-type="fig"}a). Lower dGly~equi~ intake did not influence total N and UA excretion. NH~3~ excretion decreased up to a dGly~equi~ intake of approximately 1700 mg/day and slightly increased at higher intake levels ([Figure 5](#animals-10-01392-f005){ref-type="fig"}e). NH~3~ and UA excretion were the highest with high dCys intake. The intake of dCys hardly influenced total N excretion. Almost no differences in total N and UA excretion were found among different Cho intakes and with low dCys intake ([Figure 4](#animals-10-01392-f004){ref-type="fig"}b and [Figure 5](#animals-10-01392-f005){ref-type="fig"}b). With medium and high dCys intake, total N and UA excretion were the lowest with low Cho intake ([Figure 4](#animals-10-01392-f004){ref-type="fig"}c,d and [Figure 5](#animals-10-01392-f005){ref-type="fig"}c,d). NH~3~ excretion was almost unaffected by low and medium Cho intake at low and medium dCys intake ([Figure 5](#animals-10-01392-f005){ref-type="fig"}f,g). At high dCys intake, NH~3~ excretion with medium Cho intake was the highest up to a dGly~equi~ intake of 1545 mg/day and decreased with increasing dGly~equi~ intake to the level that was excreted with low Cho intake ([Figure 5](#animals-10-01392-f005){ref-type="fig"}h). Increasing dGly~equi~ intake and decreasing dCys intake increased the UA-N/(UA-N + NH~3~-N) ratio ([Figure 6](#animals-10-01392-f006){ref-type="fig"}). The UA-N/(UA-N + NH~3~-N) ratio was almost unaffected by Cho intake and was slightly higher with low Cho intake.

3.8. Plasma Metabolites {#sec3dot8-animals-10-01392}
-----------------------

Increased dGly~equi~ intake increased plasma Gly concentrations and had nearly no effect on plasma Met concentrations ([Figure 7](#animals-10-01392-f007){ref-type="fig"}a,b). Plasma Hcys concentrations decreased and plasma Cysta concentrations increased at low and medium dCys intake when dGly~equi~ intake increased ([Figure 7](#animals-10-01392-f007){ref-type="fig"}c,d). Concentrations of these compounds were almost unaffected at high dCys intake. Plasma Met, Hcys, and Cysta concentrations decreased with increasing dCys intake. Plasma Gly concentrations were almost unaffected by dCys intake. Cho intake had nearly no effect on plasma Gly concentrations ([Figure 7](#animals-10-01392-f007){ref-type="fig"}a). Higher Cho intake increased plasma Met concentrations irrespective of dCys intake ([Figure 7](#animals-10-01392-f007){ref-type="fig"}b) and decreased plasma Hcys concentrations at low and medium dCys intake ([Figure 7](#animals-10-01392-f007){ref-type="fig"}c). Plasma Hcys concentrations were almost unaffected by Cho intake at high dCys intake. The lowest Cho intake resulted in the highest plasma Cysta concentrations, and the difference in this concentration was hardly pronounced between medium and high Cho intake ([Figure 7](#animals-10-01392-f007){ref-type="fig"}d).

4. Discussion {#sec4-animals-10-01392}
=============

The objective of the present study was to investigate the interactive effects among dietary Gly~equi~, Cys, and Cho on growth. The interactive effects among these compounds was noted on G:F; however, they were small, although the metabolism of these compounds was influenced, as shown from the plasma metabolite concentrations. More pronounced interactive effects between Gly~equi~ and Cys \[[@B6-animals-10-01392]\] and between Gly~equi~ and Cho \[[@B10-animals-10-01392]\] on growth have been reported previously. Siegert and Rodehutscord \[[@B4-animals-10-01392]\] suggested that the extent of the interactive effects between Gly~equi~ and Cys, or Gly~equi~ and Cho on growth may be affected by varying NUE and urinary N excretion because the formation of UA requires Gly. The outcomes of the present study support this suggestion.

4.1. Effects of Gly~equi~ {#sec4dot1-animals-10-01392}
-------------------------

G:F was predominately influenced by the dGly~equi~ intake as indicated by the global sensitivity analysis. The increased NUE up to a dGly~equi~ intake of approximately 1470 mg/day with medium dCys and Cho intake showed that the more of the ingested N was accreted the less limiting Gly~equi~ intake was. This likely led to a higher G:F. NUE decreased with dGly~equi~ intake above 1470 mg/day because the additional Gly~equi~ could not be used by the animals, and the N contained in the surplus Gly~equi~ had to be excreted. Domestic fowl predominately excretes N in the urine as UA, with urinary N consisting of 72%--91% of UA−N plus NH~3~−N \[[@B23-animals-10-01392]\]. One molecule of Gly is required for the formation of one molecule of UA \[[@B11-animals-10-01392]\]. A surplus dGly~equi~ intake above 1470 mg/day was mostly excreted as UA because UA excretion and the UA-N/(UA-N + NH~3~-N) ratio increased with increasing dGly~equi~ intake. Therefore, dietary Gly~equi~ fed in excess was disadvantageous when the aim was to increase NUE.

4.2. Consequences of High Nitrogen-Utilization Efficiency {#sec4dot2-animals-10-01392}
---------------------------------------------------------

Varying NUE is a considerable factor that influences the effects of dietary Gly~equi~, Cys, and Cho. The observed NUE of 77% to 80% was very high compared to that found in the literature, where NUE ranged between 50% and 65% for diets containing 240 and 170 g CP/kg \[[@B24-animals-10-01392],[@B25-animals-10-01392],[@B26-animals-10-01392]\]. A high NUE indicates low catabolism of AA, meaning that digestible AA concentrations in the diets were close to the requirement of the animals. The Gly~equi~ requirement of broiler chickens decreases when NUE increases because a lower proportion of ingested N has to be excreted via the urine as UA, for which Gly is dissipated \[[@B4-animals-10-01392]\]. Thus, the high NUE found in the present study contributed to a low Gly~equi~ requirement of the birds. A value of 95% of maximum response, often defined as the recommended concentration of a nutrient \[[@B10-animals-10-01392],[@B27-animals-10-01392]\], at a medium dCys and Cho intake was obtained at a dGly~equi~ intake of 684 mg/day (equivalent to 10 g Gly~equi~/kg). This is at the lower range of the dietary Gly~equi~ values required for broiler chickens during the first 3 weeks of age to achieve 95% of the maximum G:F that has been reported to vary between 10 and 16 g Gly~equi~/kg in previous studies \[[@B4-animals-10-01392]\]. Additional Gly~equi~ was possibly available when dCys (because of less Ser required to form Cys from Met) and Cho (because it is an endogenous precursor of Gly) intake increased. However, the additional Gly~equi~ obtained by these processes could not be used by the animals for G:F because the birds were abundantly supplied with Gly~equi~ in the investigated range of dGly~equi~ where the interactions with dCys and Cho could be determined (levels −1 to +1 based on the study design corresponding to 840 and 1310 mg dGly~equi~ intake/day, respectively). This could explain the small effects of varying dCys and Cho intake on G:F found in the present study. More pronounced interactive effects of dGly~equi~, dCys, and Cho intake on G:F would likely have occurred at a dGly~equi~ intake below 840 mg/d. The variation in NUE was small, which contributed to a similar Gly~equi~ requirement for UA excretion among treatments. Taken together, the high level and low variation in NUE resulted in a low Gly~equi~ requirement, which explains the small pronounced effects of dietary Cys and Cho on the response to dietary Gly~equi~ on growth.

This contradicts the findings by Siegert et al. \[[@B6-animals-10-01392]\], who found that the growth response to dietary Gly~equi~ was higher as dietary Cys concentrations increased. In the studies included in their meta−analysis, dietary Cys was positively correlated with dietary CP, which varied between 160 and 240 g/kg. NUE was not determined in the studies included in their meta−analysis; however, the varying dietary CP most likely influenced NUE. In contrast to the meta−analysis by Siegert et al. \[[@B6-animals-10-01392]\], the variation of dietary CP and NUE in the present study was low and CP and Cys concentrations in the diets were not correlated (*P* = 0.691). Therefore, the effects of different Cys concentrations in the present study were almost unaffected by the effects of different dietary CP on NUE and resulting implications on interactive effects of Gly~equi~ and Cys on G:F. The Cys effect found in the previous meta−analysis could have been an artifact caused by a concurrently variable CP supply.

4.3. Effects of Cysteine Formation from Methionine {#sec4dot3-animals-10-01392}
--------------------------------------------------

Different dCys intake influenced Met conversion to Cys. This probably contributed to the overall highest G:F at high dCys intake and to higher G:F response with dGly~equi~ intake at low dCys intake compared to that at high dCys intake. These findings are consistent with the results of Siegert et al. \[[@B6-animals-10-01392]\] and Powell et al. \[[@B28-animals-10-01392]\]. The formation of Cys from Met produces Hcy and Cysta as intermediates \[[@B5-animals-10-01392]\]. The plasma concentrations of Hcys and Cysta varied depending on dGly~equi~ and dCys intake in the present study. The decreasing plasma Hcys and Cysta concentrations indicated that lower proportions of Met were converted to Cys with higher dCys intake. One molecule of Ser is required when Hcy is converted to Cysta \[[@B5-animals-10-01392],[@B29-animals-10-01392]\], and one molecule of ammonia is produced when Cysta is metabolized to Cys \[[@B29-animals-10-01392]\]. Ammonia can be converted to UA during the dissipation of Gly~equi~ or it can be used to produce nonessential AA \[[@B4-animals-10-01392],[@B30-animals-10-01392],[@B31-animals-10-01392]\]. Therefore, every molecule of Met that is not metabolized to Cys spares one or two Gly~equi~ molecules. Thus, Gly~equi~ is more available for other metabolic processes such as N accretion or UA formation and could explain the slightly higher G:F and UA excretion at higher dCys intake. Conversely, more Gly~equi~ was required for Cys formation from Met to meet bird Cys requirement at lower dCys intake, which would explain the higher G:F response to Gly~equi~ supplementation at lower dCys intake than that at higher dCys intake.

4.4. Effects of Choline {#sec4dot4-animals-10-01392}
-----------------------

A low conversion of Cho to Gly might be an explanation for the smaller extent of interactive effects of Gly~equi~ and Cho compared to those of Gly~equi~ and Cys on G:F. Increasing plasma concentrations of Met together with decreasing plasma concentrations of Hcys and Cysta with increasing Cho intake indicated that a higher proportion of Hcy was remethylated to Met. Remethylation of Hcy to Met can occur via the BHMT and MS pathways \[[@B29-animals-10-01392]\]. Via BHMT, Cho is metabolized to betaine and then to dimethylglycine when one methyl group of betaine is delivered to Hcy. Subsequently, dimethylglycine is converted to Gly. Results of studies describing whether BHMT or MS prevail upon Cho supplementation are not uniform. It was reported that Cho supplementation decreased the proportion of Hcy remethylated via BHMT \[[@B32-animals-10-01392],[@B33-animals-10-01392]\] and downregulated BHMT activity \[[@B34-animals-10-01392]\] in broiler chickens. In this case, Cho would deliver methyl groups for the remethylation of Hcy via MS \[[@B32-animals-10-01392],[@B33-animals-10-01392]\] without Gly being produced. In other studies, Cho supplementation increased BHMT activity in broiler chickens \[[@B35-animals-10-01392]\], pigs \[[@B36-animals-10-01392]\], and rats \[[@B37-animals-10-01392]\]. A higher activity of BHMT led to an increased formation of Gly. The reasons for these inconsistent effects of Cho supplementation on BHMT and MS activities are unclear. Possibly, the effects of Cho supplementation on BHMT and MS activities diverged among studies and, therefore, contributed to a different extent of interactive effects between dietary Cho and Gly~equi~ on growth between the results by Siegert et al. \[[@B10-animals-10-01392]\] and the present study.

4.5. Effect of Digestible Cysteine Intake on Acid Excretion {#sec4dot5-animals-10-01392}
-----------------------------------------------------------

Higher dCys intake led to higher acid excretion. Increased acid excretion was indicated by the UA-N/(UA-N + NH~3~-N) ratio that increased with increasing dCys intake. The increasing UA-N/(UA-N + NH~3~-N) ratio was not caused by Gly~equi~ deficiency limiting UA formation as described previously \[[@B14-animals-10-01392],[@B19-animals-10-01392]\] because Gly~equi~ was adequately supplied. Dietary Cys increased by adding Cys as free [l]{.smallcaps}-Cys·HCl·H~2~O, inducing an acid load in the birds owing to the contained hydrochloride \[[@B38-animals-10-01392]\]. Therefore, it was more likely that higher NH~3~ excretion was an adaption to the excretion of acid loads to maintain the acid−base balance \[[@B39-animals-10-01392]\]. Consequences of an altered acid−base balance have the potential to decrease the growth of broiler chickens \[[@B40-animals-10-01392],[@B41-animals-10-01392]\]. For the present study, however, the mechanisms of the animals to maintain an acid−base balance were not challenged to an extent that decreased their growth because high dCys intake led to an overall high G:F.

4.6. Neural Network and Genetic Algorithm {#sec4dot6-animals-10-01392}
-----------------------------------------

Neural networks can be utilized to model, analyze, and optimize the response of broiler chickens to dietary nutrient concentrations or intake \[[@B10-animals-10-01392],[@B42-animals-10-01392]\]. The optimal number of hidden neurons and their respective coefficients must be determined for maximized prediction accuracy. In previous studies, neural networks were often designed using a time-consuming iterative trial and error approach that requires much experience in developing neural networks by the operator. Using genetic algorithms and neural networks together can overcome these disadvantage \[[@B43-animals-10-01392],[@B44-animals-10-01392],[@B45-animals-10-01392]\]. The results of the present study indicate that using genetic algorithms for training neural networks decreases operational effort, making the architecture of neural networks less dependent of the operator. This might improve the applicability of neural networks in animal nutrition science.

5. Conclusions {#sec5-animals-10-01392}
==============

The interactive effects of dietary Gly~equi~, Cys, and Cho on performance were slightly pronounced, possibly because NUE was high and barely influenced by the variation of these nutrients. The interactive effects between Gly~equi~ and Cho on growth were smaller than those between Gly~equi~ and Cys. Plasma metabolites indicated that the metabolism of Gly~equi~, Cys, and Cho was influenced by varying concentrations of these nutrients; however, the consequences for growth were small.

The following are available online at <https://www.mdpi.com/2076-2615/10/8/1392/s1>, Figure S1: Effect of digestible glycine equivalent (dGly~equi~) intake on average daily gain (ADG) of broiler chickens at varying digestible cysteine (dCys) and medium choline (Cho) intake from days 7 to 21 (**a**). The effect of dGly~equi~ intake on ADG of broiler chickens at varying Cho and low, medium, and high dCys intake from days 7 to 21 (**b--d**). dCys and Cho intake levels correspond to level −1, 0, and +1 based on the fractional composite design. Figure S2: Effect of digestible glycine equivalent (dGly~equi~) intake on average daily feed intake (ADFI) of broiler chickens at varying digestible cysteine (dCys) and medium choline (Cho) intake from days 7 to 21 (**a**) and effects of dGly~equi~ intake on ADFI of broiler chickens at varying Cho and low, medium, and high dCys intake from days 7 to 21 (**b--d**). dCys and Cho intake levels correspond to level −1, 0, and +1 based on the fractional composite design. Table S1: Analyzed concentrations of nutrients other than glycine equivalent, cysteine, and choline of the experimental diets (g/kg on a 88% dry matter basis unless otherwise stated). Table S2: Neural network model equations for gain:feed ratio, excreta characteristics, and blood metabolites. Table S3: Description of neural network models for the prediction of traits that were not further described because R^2^ was ≤ 0.50 or because model results were difficult to interpret biologically.

###### 

Click here for additional data file.
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![Relationship between diet concentrations and prececal digestible intake of glycine equivalent (dGly~equi~), cysteine (dCys), methionine (dMet), and total choline (Cho) by broiler chickens from days 7 to 21 (blue lines) and days 18 to 21 (orange lines). y is the intake (mg/d) of dGly~equi~, dCys or dMet or the total intake of Cho, and x is the dietary concentration (g/kg) of glycine equivalent (Gly~equi~), cysteine (Cys), methionine (Met), or Cho.](animals-10-01392-g001){#animals-10-01392-f001}

![Effect of digestible glycine equivalent (dGly~equi~) intake on gain:feed ratio of broiler chickens at varying digestible cysteine (dCys) and choline (Cho) intake from days 7 to 21. dCys and Cho intake levels correspond to level −1, 0, and +1 based on the fractional central composite design.](animals-10-01392-g002){#animals-10-01392-f002}

![Effect of digestible glycine equivalent (dGly~equi~) intake on nitrogen−utilization efficiency (NUE) of broiler chickens at varying digestible cysteine (dCys) and medium choline (Cho) intake from days 18 to 21 (**a**), and the effect of dGly~equi~ intake on the NUE of broiler chickens at varying Cho and low, medium, and high dCys intake from days 18 to 21 (**b**--**d**). dCys and Cho intake levels correspond to level −1, 0, and +1 based on the fractional central composite design.](animals-10-01392-g003){#animals-10-01392-f003}

![Effect of digestible glycine equivalent (dGly~equi~) intake on total nitrogen (N) excretion of broiler chickens at varying digestible cysteine (dCys) and medium choline (Cho) intake from days 18 to 21 (**a**), and effect of dGly~equi~ intake on total N excretion of broiler chickens at varying Cho and low, medium, and high dCys intake from days 18 to 21 (**b**--**d**). dCys and Cho intake levels correspond to level −1, 0, and +1 based on the fractional central composite design.](animals-10-01392-g004){#animals-10-01392-f004}

![Effect of digestible glycine equivalent (dGly~equi~) intake on uric acid (UA) (**a**) and ammonia (NH~3~) (**e**) excretion of broiler chickens at varying digestible cysteine (dCys) and medium choline (Cho) intake from days 18 to 21, and the effect of dGly~equi~ intake on UA (**b**--**d**) and NH~3~ (**f**--**h**) excretion of broiler chickens at varying Cho and low, medium, and high dCys intake from days 18 and 21. dCys and Cho intake levels correspond to level −1, 0, and +1 based on the fractional central composite design.](animals-10-01392-g005){#animals-10-01392-f005}

![Effect of digestible glycine equivalent (dGly~equi~) intake on uric acid−nitrogen/(uric acid−nitrogen + ammonia−nitrogen) ratio ((UA-N/(UA-N + NH~3~-N) ratio) in the excreta of broiler chickens at varying digestible cysteine (dCys) and choline (Cho) intake from days 18 to 21. dCys and Cho intake levels correspond to level −1, 0, and +1 based on the fractional central composite design.](animals-10-01392-g006){#animals-10-01392-f006}

![Effect of digestible glycine equivalent (dGly~equi~) intake with varying digestible cysteine (dCys) and choline (Cho) intake from days 7 to 21 on plasma glycine (Gly) (**a**), methionine (Met) (**b**), homocystine (Hcys) (**c**), and cystathionine (Cysta) (**d**) concentrations of broiler chickens on day 22. dCys and Cho intake levels correspond to level −1, 0, and +1 based on the fractional central composite design.](animals-10-01392-g007){#animals-10-01392-f007}
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###### 

Composition of the experimental diets arranged according to the fractional central composite design (g/kg).

                                       Growth Trial              Digestibility Trial                                                                                     
  ------------------------------------ ------------------------- --------------------- ------ ------ ----- ----- ------ ----- ----- ----- ----- ----- ----- ----- ------ ------
                                       Non-varying ingredients                                                                                                           
  Corn                                 794                                                                                                                               
  Casein                               84                                                                                                                                
  Soybean oil                          30                                                                                                                                
  [l]{.smallcaps}-Arginine             7.2                                                                                                                               
  [l]{.smallcaps}-Aspartic acid        6.5                                                                                                                               
  [l]{.smallcaps}-Lysine·HCl           4.8                                                                                                                               
  [l]{.smallcaps}-Valine               3.8                                                                                                                               
  [l]{.smallcaps}-Threonine            2.6                                                                                                                               
  [l]{.smallcaps}-Alanine              2.2                                                                                                                               
  [l]{.smallcaps}-Isoleucine           2.2                                                                                                                               
  [l]{.smallcaps}-Glutamic acid        1.8                                                                                                                               
  [l]{.smallcaps}-Phenylalanine        1.1                                                                                                                               
  [l]{.smallcaps}-Tryptophan           0.4                                                                                                                               
  [l]{.smallcaps}-Tyrosine             0.2                                                                                                                               
  Limestone                            15.3                                                                                                                              
  Monocalcium phosphate                15.0                                                                                                                              
  Sodium bicarbonate                   3.3                                                                                                                               
  Vitamin premix ^1^                   2.0                                                                                                                               
  Sodium chloride                      1.0                                                                                                                               
  Trace element premix ^2^             0.5                                                                                                                               
                                       Varying ingredients                                                                                                               
  [dl]{.smallcaps}-Methionine          1.7                       2.5                   2.5    0.8    0.8   3.4   1.7    1.7   1.7   \-    2.5   2.5   0.8   0.8   1.7    \-
  [l]{.smallcaps}-Cysteine·HCl·H~2~O   3.2                       1.7                   1.7    4.6    4.6   0.3   3.2    3.2   3.2   6.0   1.7   1.7   4.6   4.6   3.2    0.3
  Glycine                              0.2                       3.4                   3.4    3.4    3.4   6.6   6.6    6.6   6.6   6.6   9.7   9.7   9.7   9.7   12.9   0.2
  Choline chloride ^3^                 2.6                       1.6                   3.7    1.6    3.7   2.6   0.5    2.6   4.7   2.6   1.6   3.7   1.6   3.7   2.6    2.6
  Cornstarch                           14.4                      12.9                  10.8   11.7   9.6   9.2   10.1   8.0   5.9   6.9   6.6   4.5   5.4   3.3   1.7    14.0
  TiO~2~                               \-                        \-                    \-     \-     \-    \-    \-     \-    \-    \-    \-    \-    \-    \-    \-     5.0

^1^ Vitamin premix (Miavit GmbH, Essen, Germany) provided per kg of diet: 10,000 IU vitamin A as retinyl acetate (3a672a); 3000 IU vitamin D3 as cholecalciferol (E671); 30 IU vitamin E as all rac-α-tocopherol (3a700); 2.4 mg vitamin K3 as menadione (3a711); 100 µg biotin (3a880); 1 mg folic acid (3a316); 3 mg thiamine (3a821); 6 mg riboflavin; 6 mg pyridoxine (3a831); 30 µg vitamin B12; 50 mg nicotinamide (3a315); 14 mg calcium D-pantothenate (3a841). ^2^ Trace element premix (Gelamin Gesellschaft für Tierernährung mbH, Memmingen, Germany) provided per kg of diet: 25 mg calcium from calcium carbonate; 80 mg manganese from manganese-(II)-oxide; 60 mg zinc from zinc-sulfate; 25 mg iron from ferrous-(II)-sulfate monohydrate; 7.5 mg copper from cupric-(II)-sulfate pentahydrate; 0.6 mg iodine from calcium iodate; 0.2 mg selenium from sodium selenite; 15 mg sepiolite. ^3^ 50% Choline chloride, 373 g/kg choline concentration.

animals-10-01392-t002_Table 2

###### 

Combinations of different nutrients and calculated and analyzed nutrient concentrations (g/kg) of glycine equivalent (Gly~equi~), cysteine (Cys), and choline (Cho) in the experimental diets.

  Treatment             Level Combinations ^1^   Calculated Nutrient Concentrations   Analyzed Nutrient Concentrations                                  
  --------------------- ------------------------ ------------------------------------ ---------------------------------- ---- ------ ----- ------ ----- --------
  Growth trial                                                                                                                                          
  A                     −2                       0                                    0                                  9    3.5    1.1   9.1    3.5   n\. a.
  B                     −1                       −1                                   −1                                 12   2.75   0.8   12.2   2.6   n\. a.
  C                     −1                       −1                                   1                                  12   2.75   1.4   12.0   2.6   1.4
  D                     −1                       1                                    −1                                 12   4.25   0.8   12.0   4.4   1.0
  E                     −1                       1                                    1                                  12   4.25   1.4   12.2   4.3   1.6
  F                     0                        −2                                   0                                  15   2.0    1.1   14.9   1.8   n\. a.
  G                     0                        0                                    −2                                 15   3.5    0.5   15.1   3.4   0.8
  H (central diet)      0                        0                                    0                                  15   3.5    1.1   15.1   3.4   1.3
  I                     0                        0                                    2                                  15   3.5    1.7   15.1   3.5   2.1
  J                     0                        2                                    0                                  15   5.0    1.1   15.0   5.1   n\. a.
  K                     1                        −1                                   −1                                 18   2.75   0.8   18.1   2.7   0.9
  L                     1                        −1                                   1                                  18   2.75   1.4   18.2   2.7   1.5
  M                     1                        1                                    −1                                 18   4.25   0.8   18.4   4.4   n\. a.
  N                     1                        1                                    1                                  18   4.25   1.4   18.6   4.4   1.4
  O                     2                        0                                    0                                  21   3.5    1.1   21.3   3.6   1.3
  Digestibility trial                                                                                                                                   
  P                     −2                       −2                                   0                                  9    2.0    1.1   8.9    1.8   n\. a.

^1^ According to the fractional central composite design for treatments A--O; ^2^ Calculated concentrations were used for further calculations; ^3^ n. a. = not analyzed.

animals-10-01392-t003_Table 3

###### 

Information and criteria of the fit of the neural network models for the prediction of gain:feed ratio of broiler chickens from days 7 to 21, and excreta characteristics of broiler chickens from days 18 to 21 based on the dietary intake of digestible glycine equivalent, digestible cysteine, and total choline.

  Item                                                                G:F                                                      NUE                  Daily NH~3~ Excretion   Daily UA Excretion   UA-N/(UA-N + NH~3~-N) Ratio   Daily N Excretion                                                              
  ------------------------------------------------------------------- -------------------------------------------------------- -------------------- ----------------------- -------------------- ----------------------------- -------------------- -------------- -------------- ------ ------ ------------- -------------
  Type of network                                                     Fully connected feed forward network                                                                                                                                                                                                    
  Training algorithm                                                  Evolutionary training using Genetic Algorithms                                                                                                                                                                                          
  Network structure selection                                         Genetic algorithms to identify neural network topology                                                                                                                                                                                  
  No. of observations in training and testing set                     73                                                       32                   71                      30                   70                            31                   70             31             71     30     70            31
  Optimal number of hidden neurons identified by genetic algorithms   4                                                        5                    4                       8                    5                             4                                                                              
  Type of activation function in hidden neuron                        Hyperbolic tangent                                       Hyperbolic tangent   Hyperbolic tangent      Hyperbolic tangent   Hyperbolic tangent            Hyperbolic tangent                                                             
  Type of basing function in output neuron                            Linear                                                   Linear               Linear                  Linear               Linear                        Linear                                                                         
  R^2^                                                                0.75                                                     0.90                 0.60                    0.66                 0.83                          0.90                 0.83           0.84           0.85   0.82   0.54          0.63
  R^2^ of the whole data set                                          0.81                                                     0.61                 0.86                    0.83                 0.84                          0.56                                                                           
  Root MSE                                                            0.007 g/g                                                0.006 g/g            0.92%                   0.93%                4.48 mg/bird                  4.55 mg/bird         59.0 mg/bird   54.0 mg/bird   0.01   0.01   0.04 g/bird   0.03 g/bird
  Root MSE of the whole data set                                      0.007 g/g                                                0.92%                4.75 mg/bird            57.5 mg/bird         0.01                          0.03 g/bird                                                                    

G:F, gain:feed ratio; NUE, nitrogen−utilization efficiency; NH~3~, ammonia; UA, uric acid; UA-N/(UA-N + NH~3~-N) ratio, uric acid−nitrogen/(uric acid-nitrogen + ammonia-nitrogen) ratio; N, nitrogen.

animals-10-01392-t004_Table 4

###### 

Information and criteria of the fit of the neural network models for the prediction of some plasma amino acids and biogenic amines in broiler chickens on day 22 based on a dietary intake of digestible glycine equivalent, digestible cysteine, and total choline.

                                                                      Gly                                                      Met                  Hcys ^1^             Cysta ^2^                                 
  ------------------------------------------------------------------- -------------------------------------------------------- -------------------- -------------------- -------------------- ------ ------ ------ ------
  n                                                                   Fully connected feed forward network                                                                                                         
  Training algorithm                                                  Evolutionary training using Genetic Algorithms                                                                                               
  Network structure selection                                         Genetic algorithms to identify neural network topology                                                                                       
  No. of observations in training and testing set                     72                                                       31                   72                   31                   72     31     64     28
  Optimal number of hidden neurons identified by genetic algorithms   7                                                        7                    7                    6                                         
  Type of activation function in hidden neuron                        Hyperbolic tangent                                       Hyperbolic tangent   Hyperbolic tangent   Hyperbolic tangent                        
  Type of basing function in output neuron                            Linear                                                   Linear               Linear               Linear                                    
  R^2^                                                                0.81                                                     0.77                 0.67                 0.67                 0.50   0.65   0.47   0.63
  R^2^ of the whole data set                                          0.80                                                     0.67                 0.55                 0.51                                      
  Root MSE (mg/100 mL)                                                1.45                                                     1.69                 0.27                 0.24                 0.05   0.07   0.09   0.07
  Root MSE of the whole data set (mg/100 mL)                          1.53                                                     0.26                 0.06                 0.09                                      

^1^ 55 observations set to 0 because no concentrations were detectable, and the lowest quantified concentration of 0.05 mg/100 mL was close to 0; ^2^ 11 observations were not used for data evaluation because no concentrations were quantified, and the lowest detected concentration (0.16 mg/100 mL) was not close to 0; Gly, glycine; Met, methionine; Hcys, homocystine; Cysta, cystathionine.

animals-10-01392-t005_Table 5

###### 

Prececal digestibility (%, arithmetic mean ± SD) of crude protein and amino acids in the digestibility trial diet (n = 5).

  Item                       Prececal Digestibility
  -------------------------- ------------------------
  Crude protein              91 ± 0.8
  Lysine                     95 ± 0.9
  Methionine                 95 ± 0.9
  Cysteine                   81 ± 1.2
  Threonine                  89 ± 0.9
  Tryptophan                 90 ± 1.8
  Arginine                   96 ± 0.6
  Valine                     93 ± 0.6
  Isoleucine                 92 ± 0.8
  Leucine                    94 ± 0.6
  Histidine                  91 ± 0.8
  Phenylalanine              96 ± 0.7
  Glycine                    84 ± 1.5
  Serine                     84 ± 1.2
  Alanine                    93 ± 0.8
  Aspartic acid/asparagine   93 ± 0.8
  Glutamic acid/glutamine    92 ± 0.7
  Proline                    92 ± 0.4

animals-10-01392-t006_Table 6

###### 

Variable total effect in the neural network models for the prediction of gain:feed ratio, excreta characteristics, and plasma metabolites.

  Item                          dGly~equi~ Intake   dCys Intake   Cho Intake
  ----------------------------- ------------------- ------------- ------------
  G:F                                                             
  Sensitivity                   0.99                0.04          0.02
  Rank                          1                   2             3
  NUE                                                             
  Sensitivity                   0.78                0.55          0.35
  Rank                          1                   2             3
  Total N excretion                                               
  Sensitivity                   0.93                0.08          0.09
  Rank                          1                   3             2
  UA excretion                                                    
  Sensitivity                   0.89                0.19          0.11
  Rank                          1                   2             3
  NH~3~ excretion                                                 
  Sensitivity                   0.32                0.72          0.38
  Rank                          3                   1             2
  UA-N/(UA-N + NH~3~-N) ratio                                     
  Sensitivity                   0.63                0.54          0.06
  Rank                          1                   2             3
  Plasma Gly concentration                                        
  Sensitivity                   0.97                0.06          0.04
  Rank                          1                   2             3
  Plasma Met concentration                                        
  Sensitivity                   0.05                0.81          0.20
  Rank                          3                   1             2
  Plasma Hcys concentration                                       
  Sensitivity                   0.15                0.70          0.20
  Rank                          3                   1             2
  Plasma Cysta concentration                                      
  Sensitivity                   0.10                0.87          0.13
  Rank                          3                   1             2

dGly~equi~, digestible glycine equivalent; dCys, digestible cysteine; Cho, choline; G:F, gain:feed ratio; NUE, nitrogen−utilization efficiency; N, nitrogen; UA, uric acid; NH~3~, ammonia; UA-N/(UA-N + NH~3~-N) ratio, uric acid-nitrogen/(uric acid-nitrogen + ammonia-nitrogen) ratio; Gly, glycine; Met, methionine; Hcy, homocystine; Cysta, cystathionine.
